Fennec Pharmaceuticals shareholders approve new equity plan and amendments at annual meeting

Filed June 10, 2026 · Period ending June 10, 2026 · ~1 min read

Key Changes

• medium

  Shareholders approved a new 2026 Equity Inducement Plan with 18.6 million votes for, creating additional equity compensation capacity that will dilute existing shareholders.

  Item 5.07 verify on EDGAR →
• medium

  Amendments to the existing 2020 Equity Incentive Plan were approved with 17.4 million votes for, potentially increasing share-based compensation available to management and employees.

  Item 5.07 verify on EDGAR →
• low

  All five director nominees were re-elected with strong support (over 20 million votes each): Dr. Khalid Islam, Chris Rallis, Marco Brughera, Jodi Cook, and Jeffrey Hackman.

  Item 5.07 verify on EDGAR →